Valuation
26% of the score, 30% here after data gaps
0median 56
An operating loss over the last year: there are no earnings to price.
BNTXBioNTech SE
$99.16-3.4% 1Y
$99.16
$83.8952 weeks$119.34
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 34 out of 100, Below average
Below average. BioNTech SE scores higher than 25% of the 1,794 companies Ryufin scores.
Carried by return on capital and earnings quality, held back by valuation and return on new capital.
Healthcare median 29 · all companies 57
How the score has moved
At each fiscal year end, from the reports and price of the time18
43
34
34
202020242025today
The biggest move was up 25 points from 2020 to 2024, mostly return on new capital.
Return on capital
18% of the score, 20% here after data gaps
100median 34
Over 7 years the business earned 63% a year after tax on the capital it uses.
2%
8%
15%
25%
63%
None at 2% or less, full points from 25%full points
7 years agolatest -34%
Return on new capital
16% of the score, 18% here after data gaps
0median 49
Over 6 years yearly profit fell by 37 cents for every dollar earned. It did so while using less capital than before.
-5%
12%
-37%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score, 16% here after data gaps
42median 67
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countDown 0.5% a year over 5 years: buybacks
695%
-3%
-0.5%
0 pointsfull points
Assets against salesAssets grew 57% a year, sales 43%
012%
-2%
14%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Margins have been too thin to measure a cycle against.
Balance sheet
8% of the score, 9% here after data gaps
0median 50
What the debt weighs against the profit that has to carry it.
Interest coverAn operating loss: the interest is not covered
01.5x
12x
-20.1x
0 pointsfull points
Earnings quality
6% of the score, 7% here after data gaps
96median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 7.1% of assets
968%
0%
-8%
-7.1%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For BNTX, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2025-12-31, latest annual report FY2025.